Kiromic BioPharma
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
HUNGERFORD BRIAN officer: CFO
 Common Stock 1,000 $2.6 $2,600
Purchase
HUNGERFORD BRIAN officer: CFO
 Common Stock 1,000 $3.18 $3,180
Purchase
BERSANI PIETRO director, officer: CEO
 Common Stock 3,000 $3.28 $9,840
Purchase
NAGEL MICHAEL director
 Common Stock 1,000 $3.33 $3,330
Purchase
BERSANI PIETRO director, officer: CEO
 Common Stock 3,000 $3.23 $9,690
Purchase
MISAJON PAMELA director
 Common Stock 1,701 $2.93 $4,984
Purchase
RALSTON SHANNON 10 percent owner
 $2,000,000 Senior Secured Convertible Note 0 $2.5 $0
Option
DAHLBECK SCOTT officer: Chief Medical Officer
 Restricted Stock Units 17,240 N/A N/A
Option
DAHLBECK SCOTT officer: Chief Medical Officer
 Common Stock 17,240 N/A N/A
Purchase
CHIRIVA INTERNATI MAURIZIO director, officer: CHIEF EXECUT..
 Common Stock 2,800 $3.7 $10,357
Purchase
SCHNEIDER JERRY A.
Common Stock 5,000 $7.31 $36,550

Showing 1 to 11 of 11 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: